Free Trial

Equifax (EFX) Financials

Equifax logo
$261.55 -0.59 (-0.22%)
As of 02:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Equifax

Annual Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
604 545 696 744 520 -384 311 587 489 429
Consolidated Net Income / (Loss)
607 552 700 749 526 -378 317 598 495 435
Net Income / (Loss) Continuing Operations
607 552 700 749 526 -378 317 598 495 435
Total Pre-Tax Income
811 718 930 949 685 -414 370 747 728 637
Total Revenue
5,452 5,024 4,939 4,778 -142 3,396 3,309 3,269 -92 2,600
Net Interest Income / (Expense)
-229 -241 -183 -146 -142 -112 -104 -93 -92 -64
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
229 241 183 146 142 112 104 93 92 64
Long-Term Debt Interest Expense
229 241 183 146 142 112 104 93 92 64
Total Non-Interest Income
5,681 5,265 5,122 4,924 0.00 3,508 3,412 3,362 0.00 2,664
Other Non-Interest Income
5,681 5,265 5,122 4,924 - 3,508 3,412 3,362 - 2,664
Total Non-Interest Expense
4,639 4,332 4,066 3,786 -827 3,843 2,964 2,531 -820 1,970
Property & Liability Insurance Claims
2,519 2,335 2,177 1,981 - 1,522 - 1,211 - -
Other Operating Expenses
1,451 1,386 1,329 1,325 3,060 1,990 2,654 1,032 2,054 1,772
Depreciation Expense
670 611 560 480 391 331 310 288 265 198
Nonoperating Income / (Expense), net
-2.50 26 57 -43 - 33 26 7.70 - 6.50
Income Tax Expense
203 166 230 201 159 -36 53 149 233 202
Net Income / (Loss) Attributable to Noncontrolling Interest
3.20 6.40 4.00 4.30 6.10 6.00 6.50 11 6.30 5.70
Basic Earnings per Share
$4.88 $4.44 $5.69 $6.11 $4.28 ($3.18) $2.58 $4.89 $4.10 $3.61
Weighted Average Basic Shares Outstanding
123.80M 122.90M 122.40M 121.90M 121.50M 120.90M 120.40M 120.10M 119.30M 118.70M
Diluted Earnings per Share
$4.84 $4.40 $5.65 $6.02 $4.24 ($3.15) $2.56 $4.83 $4.04 $3.55
Weighted Average Diluted Shares Outstanding
124.90M 123.90M 123.30M 123.60M 122.80M 122M 121.40M 121.50M 121.10M 120.90M
Weighted Average Basic & Diluted Shares Outstanding
124.02M 123.96M 122.49M 122.08M 121.79M 120.80M 120.40M 120.10M 119.20M 118.90M
Cash Dividends to Common per Share
$1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.56 $1.32 $1.16

Quarterly Income Statements for Equifax

This table shows Equifax's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
133 174 141 164 125 132 162 138 112 108 166
Consolidated Net Income / (Loss)
134 173 143 165 126 135 164 139 114 109 167
Net Income / (Loss) Continuing Operations
134 173 143 165 126 135 164 139 114 109 167
Total Pre-Tax Income
185 226 194 225 167 183 191 192 152 141 220
Total Revenue
1,389 1,364 1,386 1,373 1,330 1,266 1,256 1,257 1,244 1,143 1,197
Net Interest Income / (Expense)
-53 -56 -56 -57 -60 -60 -63 -61 -58 -55 -47
Total Interest Income
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense
53 56 56 57 60 60 63 61 58 55 47
Long-Term Debt Interest Expense
53 56 56 57 60 60 63 61 58 55 47
Total Non-Interest Income
1,442 1,419 1,442 1,431 1,389 1,327 1,319 1,318 1,302 1,198 1,244
Other Non-Interest Income
1,442 1,419 1,442 1,431 1,389 1,327 1,319 1,318 1,302 1,198 1,244
Total Non-Interest Expense
1,206 1,131 1,195 1,148 1,165 1,082 1,073 1,081 1,097 1,022 1,001
Property & Liability Insurance Claims
657 - 645 - 628 - 585 - 580 539 543
Other Operating Expenses
375 -286 380 984 373 -245 333 931 366 340 318
Depreciation Expense
175 172 169 165 164 157 154 150 150 142 141
Nonoperating Income / (Expense), net
2.50 -6.80 3.00 -0.30 1.60 -1.70 7.10 16 4.40 20 24
Income Tax Expense
52 52 51 59 41 48 26 53 39 32 53
Net Income / (Loss) Attributable to Noncontrolling Interest
0.70 -0.70 1.40 1.30 1.20 2.10 2.10 1.10 1.10 1.00 1.20
Basic Earnings per Share
$1.07 $1.41 $1.14 $1.32 $1.01 $1.07 $1.32 $1.13 $0.92 $0.88 $1.35
Weighted Average Basic Shares Outstanding
124.10M 123.80M 123.90M 123.70M 123.50M 122.90M 123M 122.70M 122.60M 122.40M 122.40M
Diluted Earnings per Share
$1.06 $1.40 $1.13 $1.31 $1.00 $1.06 $1.31 $1.12 $0.91 $0.88 $1.34
Weighted Average Diluted Shares Outstanding
125.10M 124.90M 125.20M 124.80M 124.80M 123.90M 123.90M 123.80M 123.50M 123.30M 123.30M
Weighted Average Basic & Diluted Shares Outstanding
124.20M 124.02M 123.95M 123.74M 123.61M 123.96M 123.22M 122.72M 122.64M 122.49M 122.44M
Cash Dividends to Common per Share
$0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39 $0.39

Annual Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
-47 -68 61 -1,460 1,283 178 -113 207 36 -35
Net Cash From Operating Activities
1,325 1,117 757 1,335 946 314 672 816 823 769
Net Cash From Continuing Operating Activities
1,325 1,123 757 1,335 946 314 672 816 823 769
Net Income / (Loss) Continuing Operations
607 552 700 749 526 -378 317 598 495 435
Consolidated Net Income / (Loss)
607 552 700 749 526 -378 317 598 495 435
Depreciation Expense
681 620 569 490 399 337 316 291 269 200
Non-Cash Adjustments to Reconcile Net Income
15 -12 114 123 -28 -33 43 -5.80 -12 -5.50
Changes in Operating Assets and Liabilities, net
22 -36 -626 -26 49 388 -3.20 -67 71 140
Net Cash From Investing Activities
-512 -878 -960 -3,398 -493 -698 -462 -350 -1,976 -148
Net Cash From Continuing Investing Activities
-512 -878 -960 -3,398 -493 -698 -462 -350 -1,976 -148
Purchase of Investment Securities
-512 -284 -1,058 -3,405 -493 -698 -6.90 -358 -1,976 -151
Divestitures
0.00 6.90 99 1.50 0.00 0.00 - - - 2.90
Net Cash From Financing Activities
-846 -306 274 618 811 558 -311 -264 1,160 -639
Net Cash From Continuing Financing Activities
-846 -306 274 618 811 558 -311 -264 1,160 -639
Issuance of Debt
650 873 992 1,697 1,123 998 995 352 1,575 0.00
Repayment of Debt
-1,360 -957 -506 -791 -136 -257 -1,067 -323 -283 -336
Payment of Dividends
-198 -237 -194 -197 -194 -195 -198 -196 -163 -144
Other Financing Activities, Net
61 15 -17 -22 17 12 -40 -20 32 37
Effect of Exchange Rate Changes
-14 -0.80 -11 -14 19 3.50 -13 4.30 29 -17

Quarterly Cash Flow Statements for Equifax

This table details how cash moves in and out of Equifax's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
25 -298 286 -19 -16 -196 249 -68 -53 44 18
Net Cash From Operating Activities
224 325 480 268 253 322 382 262 151 325 355
Net Cash From Continuing Operating Activities
224 325 480 268 253 328 382 262 151 325 355
Net Income / (Loss) Continuing Operations
134 173 143 165 126 135 164 139 114 109 167
Consolidated Net Income / (Loss)
134 173 143 165 126 135 164 139 114 109 167
Depreciation Expense
176 174 173 167 167 159 157 152 152 145 143
Non-Cash Adjustments to Reconcile Net Income
31 -12 6.00 -2.60 23 8.20 -53 8.30 25 36 17
Changes in Operating Assets and Liabilities, net
-117 -10 157 -62 -63 27 114 -38 -140 36 28
Net Cash From Investing Activities
-107 -119 -124 -137 -132 -154 -406 -156 -163 -152 -478
Net Cash From Continuing Investing Activities
-107 -119 -124 -137 -132 -154 -406 -156 -163 -152 -478
Purchase of Investment Securities
-107 -119 -124 -137 -132 448 -406 -163 -163 -152 -479
Net Cash From Financing Activities
-96 -501 -64 -149 -132 -370 281 -174 -43 -143 152
Net Cash From Continuing Financing Activities
-96 -501 -64 -149 -132 -370 281 -174 -43 -143 152
Repayment of Debt
-48 -463 -694 -115 -88 -292 327 -831 -161 -501 -5.40
Payment of Dividends
-49 -49 -49 -51 -49 -91 -49 -50 -48 -48 -48
Other Financing Activities, Net
0.80 10 29 18 4.50 13 2.10 8.90 -9.30 16 -0.70
Effect of Exchange Rate Changes
4.40 -2.80 -4.90 -1.10 -4.70 5.30 -7.90 -0.50 2.30 13 -9.90

Annual Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
11,759 12,280 11,548 11,041 9,612 7,909 7,153 7,233 6,664 4,502
Cash and Due from Banks
170 217 285 225 1,685 401 224 336 129 93
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
1,892 1,834 1,587 1,316 -235 948 81 139 160 154
Goodwill
6,548 6,830 6,384 6,258 4,496 4,308 4,130 4,184 3,974 2,571
Intangible Assets
1,616 1,954 1,913 1,993 2,467 1,140 1,878 1,770 1,726 1,135
Other Assets
1,534 1,446 1,379 1,249 1,199 1,112 841 804 675 548
Total Liabilities & Shareholders' Equity
11,759 12,280 11,548 11,041 9,612 7,909 7,153 7,233 6,664 4,502
Total Liabilities
6,840 7,593 7,575 7,440 6,402 5,286 3,998 3,994 3,943 2,151
Short-Term Debt
826 1,161 1,218 1,036 1,260 151 181 1,076 666 90
Accrued Interest Payable
251 245 229 238 252 164 213 161 149 113
Other Short-Term Payables
735 613 568 1,017 971 1,044 433 329 444 401
Long-Term Debt
4,323 4,748 4,820 4,470 3,277 3,380 2,631 1,739 2,087 1,138
Other Long-Term Liabilities
706 826 739 678 641 548 540 690 596 409
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
105 135 0.00 - - - - - - -
Total Equity & Noncontrolling Interests
4,814 4,552 3,973 3,601 3,210 2,623 3,156 3,239 2,721 2,350
Total Preferred & Common Equity
4,797 4,534 3,957 3,584 3,168 2,579 3,108 3,174 2,663 2,311
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4,797 4,534 3,957 3,584 3,168 2,579 3,108 3,174 2,663 2,311
Common Stock
2,146 1,992 1,825 1,767 1,701 1,636 1,587 1,563 1,544 1,491
Retained Earnings
6,019 5,609 5,256 4,752 4,185 3,855 4,718 4,601 4,153 3,834
Treasury Stock
-2,645 -2,635 -2,651 -2,639 -2,547 -2,557 -2,571 -2,578 -2,506 -2,530
Accumulated Other Comprehensive Income / (Loss)
-723 -431 -474 -295 -171 -354 -626 -412 -529 -485
Noncontrolling Interest
18 18 17 17 42 44 48 65 59 40

Quarterly Balance Sheets for Equifax

This table presents Equifax's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
11,855 11,759 12,344 12,152 12,251 12,280 12,349 11,538 11,584 11,548 11,308
Cash and Due from Banks
195 170 468 182 201 217 413 164 233 285 242
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
-974 1,892 -874 -813 -746 1,834 -665 -629 -570 1,587 -498
Goodwill
6,591 6,548 6,730 6,747 6,761 6,830 6,731 6,401 6,396 6,384 6,304
Intangible Assets
4,432 1,616 4,517 4,483 4,464 1,954 4,427 4,145 4,080 1,913 3,938
Other Assets
1,611 1,534 1,503 1,554 1,571 1,446 1,443 1,457 1,446 1,379 1,323
Total Liabilities & Shareholders' Equity
11,855 11,759 12,344 12,152 12,251 12,280 12,349 11,538 11,584 11,548 11,308
Total Liabilities
6,742 6,840 7,298 7,319 7,539 7,593 7,864 7,330 7,502 7,575 7,532
Short-Term Debt
812 826 903 972 1,078 1,161 692 317 962 1,218 1,236
Accrued Interest Payable
281 251 263 238 306 245 267 271 283 229 222
Other Short-Term Payables
638 735 708 577 590 613 623 504 548 568 561
Long-Term Debt
4,324 4,323 4,721 4,743 4,745 4,748 5,500 5,503 4,988 4,820 4,819
Other Long-Term Liabilities
687 706 702 789 820 826 782 734 722 739 695
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
113 105 121 121 132 135 176 - - 0.00 -
Total Equity & Noncontrolling Interests
5,000 4,814 4,926 4,713 4,581 4,552 4,309 4,208 4,082 3,973 3,776
Total Preferred & Common Equity
4,981 4,797 4,909 4,696 4,562 4,534 4,293 4,191 4,064 3,957 3,759
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4,981 4,797 4,909 4,696 4,562 4,534 4,293 4,191 4,064 3,957 3,759
Common Stock
2,184 2,146 2,128 2,088 2,055 1,992 1,967 1,881 1,862 1,825 1,811
Retained Earnings
6,103 6,019 5,893 5,800 5,685 5,609 5,525 5,411 5,320 5,256 5,196
Treasury Stock
-2,648 -2,645 -2,647 -2,648 -2,652 -2,635 -2,635 -2,655 -2,657 -2,651 -2,651
Accumulated Other Comprehensive Income / (Loss)
-657 -723 -465 -544 -527 -431 -564 -446 -461 -474 -596
Noncontrolling Interest
19 18 17 17 19 18 16 17 18 17 17

Annual Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
8.52% 1.71% 3.37% 3,474.51% -104.17% 2.64% 1.20% 3,649.84% -103.54% 9.80%
EBITDA Growth
13.84% -8.99% -2.73% 36.65% 1,087.70% -116.63% -35.87% 3.30% 20.09% 7.28%
EBIT Growth
17.45% -20.71% -12.03% 44.83% 253.25% -229.78% -53.38% 1.47% 15.57% 10.62%
NOPAT Growth
14.52% -19.09% -15.98% 48.72% 268.13% -206.15% -50.18% 19.54% 15.04% 16.00%
Net Income Growth
10.08% -21.21% -6.45% 42.25% 239.17% -219.27% -46.99% 20.78% 13.87% 16.26%
EPS Growth
10.00% -22.12% -6.15% 41.98% 234.60% -223.05% -47.00% 19.55% 13.80% 19.53%
Operating Cash Flow Growth
18.60% 47.51% -43.28% 41.07% 201.53% -53.32% -17.62% -0.85% 7.01% 24.81%
Free Cash Flow Firm Growth
2,247.63% 78.49% 57.36% 45.93% -113.62% -231.02% 2,896.52% 100.91% -321.40% 61.02%
Invested Capital Growth
-4.98% 5.84% 9.92% 17.55% 25.90% 3.13% -1.43% 10.58% 52.97% -5.35%
Revenue Q/Q Growth
1.82% 2.51% -1.42% 822.99% -103.75% 2.03% -33.92% 303.60% -103.15% 1.67%
EBITDA Q/Q Growth
4.37% 6.27% -5.41% -2.53% 34.92% 5.18% -17.89% -1.14% 4.75% 1.59%
EBIT Q/Q Growth
6.23% 10.03% -9.55% -6.51% 63.10% -0.43% -30.38% -1.70% 3.04% 2.34%
NOPAT Q/Q Growth
7.52% 8.67% -11.63% 11.30% 67.54% -0.43% -33.90% 7.94% 2.44% 2.32%
Net Income Q/Q Growth
6.83% 4.83% -1.96% 6.46% 11.01% -3.28% -30.18% 9.06% 2.44% 3.38%
EPS Q/Q Growth
7.56% 4.27% -1.74% 6.55% 10.42% -2.94% -30.43% 9.03% 2.54% 3.50%
Operating Cash Flow Q/Q Growth
0.20% -0.29% -7.33% 7.07% 7.56% 26.58% -5.95% -8.06% 5.99% 3.99%
Free Cash Flow Firm Q/Q Growth
98.71% 85.15% -287.90% 42.88% 17.12% -150.89% -1.45% -95.28% 9.60% -14.24%
Invested Capital Q/Q Growth
-5.65% -0.75% 1.84% -1.19% 3.25% 4.28% -0.78% 1.66% -3.56% -1.78%
Profitability Metrics
- - - - - - - - - -
EBITDA Margin
27.40% 26.12% 29.19% 31.02% 0.00% -3.23% 19.96% 31.50% 0.00% 31.93%
EBIT Margin
14.91% 13.78% 17.67% 20.77% 0.00% -13.17% 10.41% 22.60% 0.00% 24.24%
Profit (Net Income) Margin
11.14% 10.98% 14.18% 15.66% 0.00% -11.13% 9.58% 18.29% 0.00% 16.72%
Tax Burden Percent
74.93% 76.85% 75.31% 78.86% 76.80% 91.37% 85.58% 80.10% 67.99% 68.30%
Interest Burden Percent
99.69% 103.71% 106.49% 95.65% 100.00% 92.55% 107.52% 101.04% 100.00% 101.03%
Effective Tax Rate
25.07% 23.15% 24.69% 21.14% 23.20% 0.00% 14.42% 19.90% 32.01% 31.70%
Return on Invested Capital (ROIC)
5.90% 5.16% 6.88% 9.29% 0.00% -5.16% 4.91% 10.27% 0.00% 11.70%
ROIC Less NNEP Spread (ROIC-NNEP)
5.86% 5.49% 7.62% 8.61% 0.00% -7.22% 5.69% 10.49% 0.00% 12.02%
Return on Net Nonoperating Assets (RNNOA)
6.75% 7.58% 11.61% 12.69% 0.00% -7.92% 5.01% 9.80% 0.00% 7.27%
Return on Equity (ROE)
12.64% 12.74% 18.49% 21.98% 18.04% -13.09% 9.91% 20.07% 19.52% 18.97%
Cash Return on Invested Capital (CROIC)
11.01% -0.51% -2.58% -6.85% -15.36% -8.25% 6.35% 0.22% -30.94% 17.19%
Operating Return on Assets (OROA)
6.76% 5.81% 7.73% 9.61% 0.00% -5.94% 4.79% 10.63% 0.00% 13.75%
Return on Assets (ROA)
5.05% 4.63% 6.20% 7.25% 0.00% -5.02% 4.41% 8.61% 0.00% 9.49%
Return on Common Equity (ROCE)
12.28% 12.49% 18.41% 21.79% 17.77% -12.88% 9.74% 19.65% 19.15% 18.66%
Return on Equity Simple (ROE_SIMPLE)
12.66% 12.17% 17.70% 20.88% 16.61% -14.66% 10.20% 18.84% 18.59% 18.82%
Net Operating Profit after Tax (NOPAT)
609 532 657 783 526 -313 295 592 495 430
NOPAT Margin
11.17% 10.59% 13.31% 16.38% 0.00% -9.22% 8.91% 18.10% 0.00% 16.55%
Net Nonoperating Expense Percent (NNEP)
0.03% -0.33% -0.74% 0.68% 0.00% 2.05% -0.79% -0.22% 0.00% -0.32%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
85.09% 86.22% 82.33% 79.23% 0.00% 113.17% 89.59% 77.40% 0.00% 75.76%
Earnings before Interest and Taxes (EBIT)
813 692 873 992 685 -447 345 739 728 630
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,494 1,312 1,442 1,482 1,085 -110 660 1,030 997 830
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
6.59 6.68 5.93 9.78 7.22 6.35 3.45 4.20 4.94 5.25
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
5.79 6.03 4.75 7.34 0.00 4.82 3.24 4.08 0.00 4.67
Price to Earnings (P/E)
52.29 55.55 33.73 47.12 43.98 0.00 34.50 22.69 26.94 28.28
Dividend Yield
0.61% 0.63% 0.81% 0.54% 0.83% 1.15% 1.76% 1.41% 1.20% 1.13%
Earnings Yield
1.91% 1.80% 2.96% 2.12% 2.27% 0.00% 2.90% 4.41% 3.71% 3.54%
Enterprise Value to Invested Capital (EV/IC)
3.64 3.41 2.92 4.43 3.33 3.18 2.24 2.62 2.90 3.72
Enterprise Value to Revenue (EV/Rev)
6.73 7.19 5.92 8.45 0.00 5.76 4.03 4.85 0.00 5.12
Enterprise Value to EBITDA (EV/EBITDA)
24.57 27.54 20.29 27.24 23.76 0.00 20.21 15.41 15.90 16.03
Enterprise Value to EBIT (EV/EBIT)
45.13 52.20 33.51 40.68 37.61 0.00 38.74 21.48 21.76 21.12
Enterprise Value to NOPAT (EV/NOPAT)
60.23 67.93 44.49 51.58 48.98 0.00 45.27 26.81 32.01 30.92
Enterprise Value to Operating Cash Flow (EV/OCF)
27.70 32.36 38.64 30.24 27.24 62.32 19.85 19.45 19.26 17.30
Enterprise Value to Free Cash Flow (EV/FCFF)
32.26 0.00 0.00 0.00 0.00 0.00 34.98 1,246.36 0.00 21.03
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.05 1.26 1.52 1.53 1.41 1.35 0.89 0.87 1.01 0.52
Long-Term Debt to Equity
0.88 1.01 1.21 1.24 1.02 1.29 0.83 0.54 0.77 0.48
Financial Leverage
1.15 1.38 1.52 1.47 1.38 1.10 0.88 0.93 0.79 0.61
Leverage Ratio
2.50 2.75 2.98 3.03 3.00 2.61 2.25 2.33 2.20 2.00
Compound Leverage Factor
2.49 2.85 3.18 2.90 3.00 2.41 2.42 2.36 2.20 2.02
Debt to Total Capital
51.14% 55.76% 60.31% 60.46% 58.57% 57.38% 47.11% 46.49% 50.29% 34.32%
Short-Term Debt to Total Capital
8.20% 10.96% 12.17% 11.38% 16.27% 2.46% 3.03% 17.77% 12.17% 2.51%
Long-Term Debt to Total Capital
42.93% 44.81% 48.15% 49.08% 42.30% 54.92% 44.09% 28.73% 38.12% 31.81%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.22% 1.45% 0.17% 0.18% 0.54% 0.72% 0.80% 1.07% 1.07% 1.10%
Common Equity to Total Capital
47.64% 42.79% 39.52% 39.36% 40.89% 41.90% 52.08% 52.44% 48.64% 64.57%
Debt to EBITDA
3.45 4.50 4.19 3.72 4.18 -32.16 4.26 2.73 2.76 1.48
Net Debt to EBITDA
3.33 4.34 3.99 3.56 2.63 -28.50 3.92 2.41 2.63 1.37
Long-Term Debt to EBITDA
2.89 3.62 3.34 3.02 3.02 -30.78 3.98 1.69 2.09 1.37
Debt to NOPAT
8.45 11.11 9.18 7.04 8.62 -11.28 9.53 4.76 5.56 2.85
Net Debt to NOPAT
8.17 10.70 8.75 6.75 5.42 -10.00 8.78 4.19 5.30 2.64
Long-Term Debt to NOPAT
7.10 8.93 7.33 5.71 6.23 -10.80 8.92 2.94 4.21 2.65
Noncontrolling Interest Sharing Ratio
2.87% 1.97% 0.44% 0.86% 1.48% 1.60% 1.76% 2.07% 1.93% 1.61%
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,137 -53 -246 -577 -1,068 -500 382 13 -1,401 633
Operating Cash Flow to CapEx
0.00% 185.73% 0.00% 0.00% 0.00% 0.00% 208.82% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
4.96 -0.22 -1.35 -3.97 -7.54 -4.48 3.69 0.14 -15.21 9.92
Operating Cash Flow to Interest Expense
5.78 4.63 4.14 9.17 6.68 2.81 6.49 8.79 8.94 12.05
Operating Cash Flow Less CapEx to Interest Expense
5.78 2.14 4.14 9.17 6.68 2.81 3.38 8.79 8.94 12.05
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.45 0.42 0.44 0.46 0.00 0.45 0.46 0.47 0.00 0.57
Fixed Asset Turnover
2.93 2.94 3.40 0.00 0.00 6.60 30.11 21.87 0.00 26.31
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
10,068 10,596 10,011 9,108 7,748 6,154 5,967 6,054 5,475 3,579
Invested Capital Turnover
0.53 0.49 0.52 0.57 0.00 0.56 0.55 0.57 0.00 0.71
Increase / (Decrease) in Invested Capital
-528 585 904 1,360 1,594 187 -87 579 1,896 -202
Enterprise Value (EV)
36,691 36,135 29,251 40,367 25,771 19,556 13,346 15,869 15,848 13,308
Market Capitalization
31,589 30,290 23,481 35,068 22,877 16,383 10,711 13,327 13,166 12,133
Book Value per Share
$38.70 $36.80 $32.31 $29.38 $26.05 $21.30 $25.77 $26.44 $22.23 $19.51
Tangible Book Value per Share
($27.16) ($34.49) ($35.45) ($38.25) ($31.19) ($23.70) ($24.05) ($23.15) ($25.36) ($11.78)
Total Capital
10,068 10,596 10,011 9,108 7,748 6,154 5,967 6,054 5,475 3,579
Total Debt
5,149 5,909 6,038 5,507 4,538 3,531 2,811 2,815 2,753 1,228
Total Long-Term Debt
4,323 4,748 4,820 4,470 3,277 3,380 2,631 1,739 2,087 1,138
Net Debt
4,979 5,692 5,753 5,282 2,853 3,130 2,588 2,478 2,624 1,135
Capital Expenditures (CapEx)
0.00 601 0.00 0.00 0.00 0.00 322 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
1.87 -20 -43 34 0.00 65 -22 -6.17 0.00 -4.44
Net Nonoperating Obligations (NNO)
5,149 5,909 6,038 5,507 4,538 3,531 2,811 2,815 2,753 1,228
Total Depreciation and Amortization (D&A)
681 620 569 490 399 337 316 291 269 200
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$4.88 $4.44 $5.69 $6.11 $4.28 ($3.30) $2.49 $4.89 $4.10 $3.61
Adjusted Weighted Average Basic Shares Outstanding
123.80M 122.90M 122.40M 121.90M 121.50M 120.90M 120.40M 120.10M 119.30M 118.70M
Adjusted Diluted Earnings per Share
$4.84 $4.40 $5.65 $6.02 $4.24 ($3.27) $2.47 $4.83 $4.04 $3.55
Adjusted Weighted Average Diluted Shares Outstanding
124.90M 123.90M 123.30M 123.60M 122.80M 122M 121.40M 121.50M 121.10M 120.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 ($3.30) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
124.02M 123.96M 122.49M 122.08M 121.79M 121.24M 120.70M 120.12M 119.85M 118.71M
Normalized Net Operating Profit after Tax (NOPAT)
609 532 657 783 -2,759 -313 295 592 -1,640 430
Normalized NOPAT Margin
11.17% 10.59% 13.31% 16.38% 0.00% -9.22% 8.91% 18.10% 0.00% 16.55%
Pre Tax Income Margin
14.87% 14.29% 18.82% 19.86% 0.00% -12.19% 11.20% 22.84% 0.00% 24.49%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
3.55 2.87 4.77 6.82 4.84 -4.00 3.33 7.96 7.91 9.88
NOPAT to Interest Expense
2.66 2.20 3.59 5.37 3.72 -2.80 2.85 6.38 5.38 6.75
EBIT Less CapEx to Interest Expense
3.55 0.38 4.77 6.82 4.84 -4.00 0.22 7.96 7.91 9.88
NOPAT Less CapEx to Interest Expense
2.66 -0.29 3.59 5.37 3.72 -2.80 -0.26 6.38 5.38 6.75
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
32.57% 43.03% 27.73% 26.25% 36.89% -51.65% 62.52% 32.74% 33.00% 33.16%
Augmented Payout Ratio
32.57% 43.03% 27.73% 35.59% 36.89% -51.65% 62.52% 45.64% 33.00% 78.31%

Quarterly Metrics And Ratios for Equifax

This table displays calculated financial ratios and metrics derived from Equifax's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.47% 7.69% 10.28% 9.25% 6.85% 10.74% 4.94% -1.43% -5.98% -5.87% 0.78%
EBITDA Growth
8.35% 18.23% 7.02% 19.34% 10.53% 29.10% 0.47% -18.92% -30.56% -23.65% -5.05%
EBIT Growth
10.85% 25.84% 3.92% 27.64% 11.64% 51.93% -6.23% -33.00% -49.50% -43.14% -17.80%
NOPAT Growth
5.69% 31.51% -11.18% 29.37% 13.31% 44.81% 6.35% -36.08% -48.65% -50.75% -19.78%
Net Income Growth
6.11% 28.85% -13.15% 18.51% 11.10% 23.28% -1.56% -30.78% -49.06% -11.37% -19.22%
EPS Growth
6.00% 32.08% -13.74% 16.96% 9.89% 20.45% -2.24% -31.29% -49.44% -10.20% -19.28%
Operating Cash Flow Growth
-11.40% 0.84% 25.62% 2.06% 67.46% -1.01% 7.55% -4.79% 176.02% -15.55% -10.92%
Free Cash Flow Firm Growth
210.44% 257.30% 121.25% -73.17% -448.00% 44.55% -48.18% 89.50% 96.00% 30.75% 69.63%
Invested Capital Growth
-2.72% -4.98% -0.05% 5.18% 5.02% 5.84% 8.61% 3.42% 1.82% 9.92% 6.65%
Revenue Q/Q Growth
1.87% -1.58% 0.90% 3.27% 5.02% 0.79% -0.05% 1.00% 8.83% -4.49% -6.11%
EBITDA Q/Q Growth
-11.50% 11.48% -7.04% 18.15% -3.44% 0.91% 3.66% 9.43% 12.78% -21.46% -16.35%
EBIT Q/Q Growth
-21.27% 21.75% -15.16% 36.30% -10.62% 0.54% 4.20% 19.22% 21.65% -37.95% -25.55%
NOPAT Q/Q Growth
-26.06% 27.07% -15.07% 32.45% -8.00% -14.18% 23.71% 16.01% 17.57% -36.98% -25.64%
Net Income Q/Q Growth
-22.79% 21.44% -13.62% 31.01% -6.25% -18.14% 17.86% 22.82% 4.03% -34.63% -17.13%
EPS Q/Q Growth
-24.29% 23.89% -13.74% 31.00% -5.66% -19.08% 16.96% 23.08% 3.41% -34.33% -17.79%
Operating Cash Flow Q/Q Growth
-31.07% -32.26% 79.25% 5.86% -21.55% -15.61% 45.63% 73.69% -53.63% -8.31% 28.91%
Free Cash Flow Firm Q/Q Growth
-40.74% 383.29% 141.33% 6.71% 15.59% 34.71% -236.82% -195.22% 91.46% -74.46% 76.13%
Invested Capital Q/Q Growth
1.79% -5.65% 1.17% 0.12% -0.57% -0.75% 6.46% -0.03% 0.20% 1.84% 1.38%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
25.87% 29.77% 26.29% 28.53% 24.94% 27.12% 27.09% 26.12% 24.11% 23.26% 28.29%
EBIT Margin
13.17% 17.04% 13.77% 16.38% 12.41% 14.58% 14.61% 14.02% 11.88% 10.63% 16.35%
Profit (Net Income) Margin
9.63% 12.71% 10.30% 12.03% 9.48% 10.62% 13.08% 11.09% 9.12% 9.54% 13.94%
Tax Burden Percent
72.17% 76.85% 73.63% 73.55% 75.69% 73.54% 86.16% 72.57% 74.57% 77.16% 75.97%
Interest Burden Percent
101.37% 97.07% 101.57% 99.87% 100.97% 99.08% 103.87% 109.02% 102.98% 116.38% 112.21%
Effective Tax Rate
27.83% 23.15% 26.37% 26.45% 24.31% 26.46% 13.84% 27.43% 25.43% 22.84% 24.03%
Return on Invested Capital (ROIC)
5.04% 6.91% 5.09% 6.12% 4.67% 5.23% 6.02% 4.99% 4.33% 4.24% 6.54%
ROIC Less NNEP Spread (ROIC-NNEP)
5.07% 6.81% 5.12% 6.11% 4.69% 5.21% 6.12% 5.19% 4.38% 4.50% 6.85%
Return on Net Nonoperating Assets (RNNOA)
5.66% 7.84% 6.35% 7.80% 6.27% 7.18% 9.07% 7.56% 6.61% 6.86% 10.94%
Return on Equity (ROE)
10.70% 14.75% 11.44% 13.92% 10.94% 12.41% 15.09% 12.56% 10.93% 11.10% 17.48%
Cash Return on Invested Capital (CROIC)
8.69% 11.01% 5.36% 0.64% 0.41% -0.51% -3.48% 1.51% 3.76% -2.58% 1.38%
Operating Return on Assets (OROA)
6.02% 7.73% 5.97% 7.23% 5.32% 6.15% 6.06% 5.96% 5.02% 4.65% 7.32%
Return on Assets (ROA)
4.40% 5.76% 4.47% 5.31% 4.07% 4.48% 5.42% 4.72% 3.86% 4.17% 6.24%
Return on Common Equity (ROCE)
10.39% 14.33% 11.04% 13.68% 10.73% 12.17% 14.71% 12.50% 10.89% 11.05% 17.40%
Return on Equity Simple (ROE_SIMPLE)
12.35% 0.00% 11.58% 12.57% 12.37% 0.00% 12.26% 12.62% 14.54% 0.00% 19.00%
Net Operating Profit after Tax (NOPAT)
132 179 140 165 125 136 158 128 110 94 149
NOPAT Margin
9.50% 13.09% 10.14% 12.05% 9.39% 10.72% 12.59% 10.17% 8.86% 8.20% 12.42%
Net Nonoperating Expense Percent (NNEP)
-0.03% 0.09% -0.04% 0.00% -0.02% 0.02% -0.10% -0.20% -0.05% -0.27% -0.31%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
86.83% 82.96% 86.23% 83.62% 87.59% 85.42% 85.39% 85.98% 88.12% 89.37% 83.65%
Earnings before Interest and Taxes (EBIT)
183 232 191 225 165 185 184 176 148 122 196
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
359 406 364 392 332 343 340 328 300 266 339
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.06 6.59 7.41 6.38 7.21 6.68 5.20 6.84 6.06 5.93 5.51
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
5.48 5.79 6.79 5.74 6.44 6.03 4.56 5.92 5.07 4.75 4.14
Price to Earnings (P/E)
49.33 52.29 64.64 51.37 59.00 55.55 42.88 54.64 41.97 33.73 29.18
Dividend Yield
0.64% 0.61% 0.53% 0.64% 0.58% 0.63% 0.86% 0.67% 0.78% 0.81% 0.92%
Earnings Yield
2.03% 1.91% 1.55% 1.95% 1.69% 1.80% 2.33% 1.83% 2.38% 2.96% 3.43%
Enterprise Value to Invested Capital (EV/IC)
3.44 3.64 3.90 3.38 3.67 3.41 2.65 3.42 3.03 2.92 2.70
Enterprise Value to Revenue (EV/Rev)
6.40 6.73 7.78 6.82 7.57 7.19 5.78 7.09 6.25 5.92 5.30
Enterprise Value to EBITDA (EV/EBITDA)
23.19 24.57 29.11 25.33 28.79 27.54 22.93 27.85 23.19 20.29 17.42
Enterprise Value to EBIT (EV/EBIT)
42.46 45.13 54.43 47.01 54.53 52.20 45.00 53.54 41.70 33.51 27.51
Enterprise Value to NOPAT (EV/NOPAT)
57.26 60.23 73.52 60.93 70.76 67.93 57.84 71.40 54.92 44.49 35.69
Enterprise Value to Operating Cash Flow (EV/OCF)
27.23 27.70 31.51 29.12 31.74 32.36 25.27 31.40 27.44 38.64 32.50
Enterprise Value to Free Cash Flow (EV/FCFF)
39.07 32.26 72.79 541.40 906.91 0.00 0.00 230.83 81.29 0.00 202.63
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.00 1.05 1.11 1.18 1.24 1.26 1.38 1.38 1.46 1.52 1.60
Long-Term Debt to Equity
0.85 0.88 0.94 0.98 1.01 1.01 1.23 1.31 1.22 1.21 1.28
Financial Leverage
1.12 1.15 1.24 1.28 1.34 1.38 1.48 1.46 1.51 1.52 1.60
Leverage Ratio
2.45 2.50 2.59 2.62 2.71 2.75 2.86 2.83 2.90 2.98 3.05
Compound Leverage Factor
2.49 2.43 2.63 2.62 2.74 2.73 2.97 3.09 2.98 3.47 3.43
Debt to Total Capital
50.12% 51.14% 52.71% 54.17% 55.27% 55.76% 58.00% 58.04% 59.31% 60.31% 61.59%
Short-Term Debt to Total Capital
7.92% 8.20% 8.47% 9.21% 10.23% 10.96% 6.48% 3.16% 9.58% 12.17% 12.57%
Long-Term Debt to Total Capital
42.19% 42.93% 44.24% 44.96% 45.04% 44.81% 51.52% 54.87% 49.72% 48.15% 49.02%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.28% 1.22% 1.29% 1.30% 1.43% 1.45% 1.79% 0.17% 0.18% 0.17% 0.17%
Common Equity to Total Capital
48.60% 47.64% 46.00% 44.52% 43.30% 42.79% 40.21% 41.79% 40.51% 39.52% 38.24%
Debt to EBITDA
3.38 3.45 3.93 4.06 4.33 4.50 5.02 4.72 4.54 4.19 3.97
Net Debt to EBITDA
3.25 3.33 3.60 3.93 4.18 4.34 4.68 4.59 4.37 3.99 3.81
Long-Term Debt to EBITDA
2.84 2.89 3.30 3.37 3.53 3.62 4.46 4.46 3.81 3.34 3.16
Debt to NOPAT
8.34 8.45 9.93 9.77 10.65 11.11 12.65 12.10 10.76 9.18 8.14
Net Debt to NOPAT
8.02 8.17 9.10 9.46 10.29 10.70 11.81 11.76 10.34 8.75 7.81
Long-Term Debt to NOPAT
7.02 7.10 8.33 8.11 8.68 8.93 11.24 11.44 9.02 7.33 6.48
Noncontrolling Interest Sharing Ratio
2.86% 2.87% 3.45% 1.71% 1.91% 1.97% 2.52% 0.41% 0.44% 0.44% 0.44%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
419 707 146 -354 -379 -449 -688 -204 -69 -810 -464
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
7.91 12.66 2.60 -6.17 -6.35 -7.45 -10.95 -3.36 -1.20 -14.83 -9.86
Operating Cash Flow to Interest Expense
4.23 5.82 8.52 4.67 4.23 5.34 6.08 4.32 2.62 5.96 7.54
Operating Cash Flow Less CapEx to Interest Expense
4.23 5.82 8.52 4.67 4.23 5.34 6.08 4.32 2.62 5.96 7.54
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.46 0.45 0.43 0.44 0.43 0.42 0.41 0.43 0.42 0.44 0.45
Fixed Asset Turnover
0.00 2.93 0.00 0.00 0.00 2.94 0.00 0.00 0.00 3.40 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,249 10,068 10,671 10,548 10,536 10,596 10,677 10,029 10,032 10,011 9,831
Invested Capital Turnover
0.53 0.53 0.50 0.51 0.50 0.49 0.48 0.49 0.49 0.52 0.53
Increase / (Decrease) in Invested Capital
-287 -528 -5.70 519 504 585 846 332 179 904 613
Enterprise Value (EV)
35,280 36,691 41,655 35,641 38,683 36,135 28,310 34,334 30,364 29,251 26,551
Market Capitalization
30,207 31,589 36,361 29,971 32,910 30,290 22,339 28,660 24,629 23,481 20,721
Book Value per Share
$40.16 $38.70 $39.67 $37.99 $36.94 $36.80 $34.98 $34.17 $33.18 $32.31 $30.71
Tangible Book Value per Share
($48.71) ($27.16) ($51.22) ($52.86) ($53.96) ($34.49) ($55.94) ($51.82) ($52.35) ($35.45) ($52.96)
Total Capital
10,249 10,068 10,671 10,548 10,536 10,596 10,677 10,029 10,032 10,011 9,831
Total Debt
5,136 5,149 5,624 5,714 5,823 5,909 6,192 5,820 5,949 6,038 6,055
Total Long-Term Debt
4,324 4,323 4,721 4,743 4,745 4,748 5,500 5,503 4,988 4,820 4,819
Net Debt
4,941 4,979 5,156 5,532 5,622 5,692 5,780 5,656 5,717 5,753 5,813
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
-1.80 5.23 -2.21 0.22 -1.21 1.25 -6.12 -12 -3.28 -15 -18
Net Nonoperating Obligations (NNO)
5,136 5,149 5,624 5,714 5,823 5,909 6,192 5,820 5,949 6,038 6,055
Total Depreciation and Amortization (D&A)
176 174 173 167 167 159 157 152 152 145 143
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.07 $1.41 $1.14 $1.32 $1.01 $1.07 $1.32 $1.13 $0.92 $0.88 $1.35
Adjusted Weighted Average Basic Shares Outstanding
124.10M 123.80M 123.90M 123.70M 123.50M 122.90M 123M 122.70M 122.60M 122.40M 122.40M
Adjusted Diluted Earnings per Share
$1.06 $1.40 $1.13 $1.31 $1.00 $1.06 $1.31 $1.12 $0.91 $0.88 $1.34
Adjusted Weighted Average Diluted Shares Outstanding
125.10M 124.90M 125.20M 124.80M 124.80M 123.90M 123.90M 123.80M 123.50M 123.30M 123.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
124.20M 124.02M 123.95M 123.74M 123.61M 123.96M 123.22M 122.72M 122.64M 122.49M 122.44M
Normalized Net Operating Profit after Tax (NOPAT)
132 179 140 165 125 136 158 128 110 94 149
Normalized NOPAT Margin
9.50% 13.09% 10.14% 12.05% 9.39% 10.72% 12.59% 10.17% 8.86% 8.20% 12.42%
Pre Tax Income Margin
13.35% 16.54% 13.99% 16.36% 12.53% 14.44% 15.18% 15.28% 12.23% 12.37% 18.35%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.46 4.16 3.39 3.93 2.76 3.06 2.92 2.90 2.57 2.23 4.16
NOPAT to Interest Expense
2.50 3.20 2.50 2.89 2.09 2.25 2.52 2.11 1.91 1.72 3.16
EBIT Less CapEx to Interest Expense
3.46 4.16 3.39 3.93 2.76 3.06 2.92 2.90 2.57 2.23 4.16
NOPAT Less CapEx to Interest Expense
2.50 3.20 2.50 2.89 2.09 2.25 2.52 2.11 1.91 1.72 3.16
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
32.15% 32.57% 42.23% 40.59% 42.19% 43.03% 37.03% 36.64% 32.78% 27.73% 27.05%
Augmented Payout Ratio
32.15% 32.57% 42.23% 40.59% 42.19% 43.03% 37.03% 36.64% 32.78% 27.73% 27.05%

Frequently Asked Questions About Equifax's Financials

When does Equifax's financial year end?

According to the most recent income statement we have on file, Equifax's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Equifax's net income changed over the last 9 years?

Equifax's net income appears to be on an upward trend, with a most recent value of $607.30 million in 2024, rising from $434.80 million in 2015. The previous period was $551.70 million in 2023. See where experts think Equifax is headed by visiting Equifax's forecast page.

How has Equifax revenue changed over the last 9 years?

Over the last 9 years, Equifax's total revenue changed from $2.60 billion in 2015 to $5.45 billion in 2024, a change of 109.7%.

How much debt does Equifax have?

Equifax's total liabilities were at $6.84 billion at the end of 2024, a 9.9% decrease from 2023, and a 218.0% increase since 2015.

How much cash does Equifax have?

In the past 9 years, Equifax's cash and equivalents has ranged from $93.30 million in 2015 to $1.68 billion in 2020, and is currently $169.90 million as of their latest financial filing in 2024.

How has Equifax's book value per share changed over the last 9 years?

Over the last 9 years, Equifax's book value per share changed from 19.51 in 2015 to 38.70 in 2024, a change of 98.4%.



This page (NYSE:EFX) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners